BUY Eris Lifesciences — PAWAN MAHESHWARI, 08 Sept 2026

byPawan MaheshwariHorizon: NA (inferred Swing (≤2wk))8 Sept 2026via CNBC Awaaz.

Entry₹1,320.3Inferred

Target₹1,360

Stop loss₹1,305-1.16% risk

CMP₹1,323Just now

Active+0.20%+2.80%upside left 13d left

Follow Pawan Maheshwari for new calls(43% target hit, 14 closed calls)Get alerts Watch ERIS for new buy/sell callsGet alerts See 1 other Swing call on ERIS See 208 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 9 Sept, 10:47 am IST

6 supporting0 opposing

Supports the BUY call (6)

MACD above its signal line — bullish momentum

Technicals · macd·9 Sept · today

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·7 Sept · 2d ago

Eris Lifesciences: லாபத்தில் **73%** அதிரடி வளர்ச்சி - பங்கு முதலீட்டாளர்கள் கவனத்திற்கு!

NewsGoogle News·2 Sept · 6d ago

Eris Lifesciences FY26 Revenue ₹3,129 Cr

NewsGoogle News·2 Sept · 6d ago

Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targets

NewsEt-Markets·28 Aug · 2w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Eris Lifesciences Limited — Pawan Maheshwari

AI Assessment